AstraZeneca Pharma India Ltd. — Board/Management Information 2022

Aug 8, 2022

==> picture [475 x 20] intentionally omitted <==

==> picture [475 x 20] intentionally omitted <==

==> picture [475 x 21] intentionally omitted <==

==> picture [475 x 20] intentionally omitted <==

==> picture [475 x 7] intentionally omitted <==

August 8, 2022

The Manager �Listing BSE Limited , 1[st] Floor, New Trading Ring Rotunda Building, P J Towers, Dalal Street, Fort, Mumbai 400001

The Manager �Listing National Stock Exchange of India Ltd. Exchange plaza, 5[th] Floor, Plot No.C/1, G Block Bandra Kurla Complex, Bandra (E), Mumbai 400051

Dear Sir(s),

Sub: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Ref: Scrip Code BSE: 506820 / NSE: ASTRAZEN

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (�Listing Regulations�), we wish to inform you that Mr. Pratap Rudra, Company Secretary has resigned as Company Secretary and Compliance Officer of the Company with effect from close of working hours of August 10, 2022. While taking note of the same, the Board has placed on record its sincere thanks and appreciation for his contribution during his tenure in the Company .

Further, the Board has appointed Ms. Manasa. R as the Company Secretary and Compliance Officer of the Company w.e.f. August 11, 2022.

In this regard, please find below details pursuant to Regulation 30 of Listing Regulations read with Clause 7 of the SEBI Circular dated September 09, 2015.

Sl.	Particulars	Information about the change	Information about the change
		Resignation of Mr. Pratap Rudra	Appointment of Ms. Manasa. R
1.	Reason for change viz. appointment, resignation, removal, death or otherwise	Resignation of Mr. Pratap Rudra as the Company Secretary and Compliance Officer of the Company.	Appointment of Ms. Manasa. R as the Company Secretary and Compliance Officer of the Company.
2.	Date of appointment/cessation	August 10, 2022 (cessation)	August 11, 2022 (appointment)

==> picture [426 x 25] intentionally omitted <==

==> picture [426 x 25] intentionally omitted <==

==> picture [426 x 15] intentionally omitted <==

==> picture [475 x 20] intentionally omitted <==

==> picture [475 x 20] intentionally omitted <==

==> picture [475 x 21] intentionally omitted <==

==> picture [475 x 20] intentionally omitted <==

==> picture [475 x 7] intentionally omitted <==

( o	as applicable) & term f appointment
3. a	Brief profile (in case of ppointment)		Ms. Manasa. R is an associate member of Institute of Company Secretaries of India. She has experience in Company Secretarial matters, securities laws and other corporate laws. She holds Bachelor Degree in Commerce and she is a Graduate in Law. She has been associated with the Company for over 6 years.
4. r a	Disclosure of elationships between directors (in case of ppointment of a Director)		Neither related to any director on the Board of Directors of the Company nor with the promoter of the Company.

Please take the same on record.

Thanking you,

For AstraZeneca Pharma India Limited

Pratap Rudra Company Secretary & Legal Counsel

==> picture [426 x 25] intentionally omitted <==

==> picture [426 x 25] intentionally omitted <==

==> picture [426 x 15] intentionally omitted <==